Trials / Unknown
UnknownNCT01126931
Wormwood in Chronic Progressive Disorders With Reduced Appetite
Pilot Trial With Wormwood to Improve Appetite in Cancer, Autoimmune Diseases, Depression and Old Age
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- University Hospital Freiburg · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Wormwood is approved herbal medicine for the treatment of reduced appetite in Germany (Registration No.: 1339.99.99). Reduced appetite is observed in many chronic health disorders such as old age, immune disorders and cancer. Trial aims at observing beneficial effects of wormwood supplementation in various chronic disorders associated with reduced appetite
Detailed description
Supplementation with wormwood in chronic disorders associated with reduced appetite. Examples: 1. Cancer 2. Autoimmune diseases such as Crohns disease and IgA Nephropathy 3. Old age 4. Chronic stress and depression
Conditions
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2012-08-01
- Completion
- 2012-12-01
- First posted
- 2010-05-20
- Last updated
- 2010-05-20
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01126931. Inclusion in this directory is not an endorsement.